ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,427,000 | -22.7% | 26,908 | -18.2% | 0.08% | -25.0% |
| Q2 2021 | $3,139,000 | -16.7% | 32,911 | -0.5% | 0.10% | -21.8% |
| Q1 2021 | $3,769,000 | -10.3% | 33,092 | +9.0% | 0.13% | -7.0% |
| Q4 2020 | $4,204,000 | +30.6% | 30,365 | -22.5% | 0.14% | +36.2% |
| Q3 2020 | $3,219,000 | +425.1% | 39,188 | +212.2% | 0.10% | +483.3% |
| Q2 2016 | $613,000 | -10.8% | 12,552 | +15.7% | 0.02% | -14.3% |
| Q1 2016 | $687,000 | +37.1% | 10,852 | +143.3% | 0.02% | +50.0% |
| Q4 2015 | $501,000 | +13.9% | 4,461 | -2.3% | 0.01% | +7.7% |
| Q3 2015 | $440,000 | – | 4,567 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |